Introduction. We performed a meta-analysis with the aim of assessing the association of the angiotensin II type 1 (AT 1 ) receptor gene A1166C polymorphism with essential hypertension in Chinese case-control studies. Methods. Studies were searched from the Chinese Biomedicine Database, the China National Knowledge Infrastructure platform, Pubmed and Medline, using the search terms 'hypertension', 'angiotensin II type 1 receptor', 'AT 1 R', 'polymorphism', 'China' and 'Chinese', without limiting to any specific language. The strength of the association between the A1166C polymorphism and hypertension was evaluated by the odds ratio (OR) with the corresponding 95% confidence interval (CI). The analyses were performed with Cochrane RevMan software version 4.2. Results. Overall, the variant genotype AC/CC was associated with a statistically increased essential hypertension risk with the pooled OR 1.48 (95% CI: 1.20-1.83). In the subgroup analyses, the association was also significant among studies using Northern populations, Southern populations, Han Chinese and hospitalbased controls. The age did not influence the relationship between the AT 1 receptor A1166C polymorphism and hypertension in the subgroup analyses. Conclusions. The present meta-analysis suggests that the AT 1 receptor 1166 AC/CC genotype is associated with susceptibility to hypertension in the Chinese population.
Introduction
Essential hypertension remains a major public health problem throughout the world and genetic elements are considered as aetiologic factors for the blood pressure variability. 1 Using the knowledge of pathways involved in blood pressure regulation, many genes have been recognised as candidates for contribution to hypertension, such as those of the renin-angiotensin system, of which some components play important roles in normal blood pressure regulation and in the pathophysiological progression of hypertension and cardiovascular diseases. 2 The polymorphisms of the angiotensin-converting enzyme gene, 3, 4 angiotensinogen gene 5, 6 and angiotensin II receptor gene [7] [8] [9] have been identified as genetic factors involved in the pathogenesis of high blood pressure and related cardiovascular events.
Classically, the angiotensin II receptor includes two subtypes: type 1 (AT 1 ) receptor and type 2 receptor. 10 The AT 1 receptor, which is the primary pathogenic effector for angiotensin II, is a member of the G-protein-coupled receptor superfamily expressed in most tissues, where receptor activation leads to vasoconstriction, water retention and vascular smooth muscle cell proliferation and hypertrophy. 11, 12 The AT 1 receptor gene, composed of five exons and four introns, is located on the long arm of chromosome 3 (3q21- 25) . Several polymorphisms of the AT 1 receptor have been identified, but the most studied A1166C variant is located in the 3' untranslated region, in which there is either an adenine (A) or a cytosine (C) base (A/C transversion). 13, 14 Bonnardeaux et al. 13 reported that the A1166C polymorphism was associated with increased prevalence of hypertension in a Caucasian population and this association has been confirmed in several subsequent reports. [14] [15] [16] On the other hand, some studies failed to confirm an association between the A1166C polymorphism and hypertension among different races and sexes. 17, 18 These discrepancies have also been found in Chinese population, giving rise to controversy in the literature.
In this study, we performed a carefully designed meta-analysis to study the association of the AT 1 receptor A1166C polymorphism with hypertension in Chinese case-control studies. We collected a total of 51 published studies and conducted such a meta-analysis with the intention of providing more reliable findings on the significance of the association.
Methods

Selection of studies
We conducted a systematic computerised literature search for studies published before 12 May 2009. We searched the Chinese Biomedicine Database, the China National Knowledge Infrastructure platform, Pubmed and Medline, using the search terms 'hypertension', 'angiotensin II type 1 receptor', 'AT 1 R', 'polymorphism', 'China' and 'Chinese', without limiting to any specific language. The full texts of the retrieved studies were carefully read to assess if they should be included in the meta-analysis. All of the references cited in the studies were also searched to identify potentially relevant articles. Studies that examined the association between A1166C genotypes and essential hypertension using case-control design and containing available genotype frequency were eligible for inclusion in the meta-analysis. Case reports, review articles and studies without normal controls were excluded.
Data extraction
Two workers examined the retrieved studies to extract the standard information from independent studies. From each study, the following information was abstracted: first author, year of publication, ethnicity, resident geography, numbers of the cases and controls, the genotype detecting method and average case and control characteristics (age, sex, body mass index). Frequencies of alleles were calculated for cases and controls from the corresponding genotype distributions.
Statistical analysis
The strength of the association between the A1166C polymorphism and hypertension was evaluated by the odds ratio (OR) with the corresponding 95% confidence interval (CI). Based on the individual OR, a pooled OR was estimated, of which the statistical significance was determined using the Z-test.
Heterogeneity among the included studies was checked by the Q-statistic. If p<0.05, then the heterogeneity was considered significant, indicating heterogeneity across studies. The random-effects model using the DerSimonian Laird method 19 was selected for meta-analysis. Alternatively, fixedeffects model using the Mantel-Haenszel method 20 was used. Sensitivity analyses were also performed to assess the stability of the results. All analyses were performed with Cochrane RevMan software version 4.2 (Cochrane Library, UK).
Results
Eligible studies considered in the meta-analysis
Fifty-one studies were identified from literature online concerning the AT 1 receptor A1166C polymorphism and essential hypertension. Of the studies with the same or overlapping data published by the same investigators, we selected the most recent ones with the largest number of participants and thus discarded 11 articles. Nine studies were excluded, because they did not provide allele frequencies needed for OR calculation. One article was also excluded due to its severe deviation from Hardy-Weinberg equilibrium (HWE) in the control group. Finally, 30 articles, containing 6,045 cases and 5,556 controls, were identified as being appropriate for the meta-analysis. The characteristics of the selected studies are summarised in table 1. The design in all the studies was case-control. These studies encompassed 18 Northern Chinese groups and 13 Southern Chinese groups. Seventeen studies dealt with Han Chinese distributed among different provinces, one with Kazakans and one with Uygur. One study investigated three ethnicities together: Han, Tibetans and Yi, and another study investigated two ethnicities: Han and Dongxiang. Nine studies did not indicate the ethnicity in their articles. Most studies included in the meta-analysis determined the genetic polymorphisms by the classic polymerase chain reaction-restriction fragment length polymorphism assay, except one by direct DNA sequencing. The studies were published between 1998 and 2009.
Association between the A1166C polymorphism and hypertension
The A1166C genotype distribution and the allele frequency for cases and controls are summarised in table 2. The significance level (p) for HWE testing for controls was calculated (table 2) . We observed a wide variation of the C allele frequencies across different studies, ranging from 0.019-0.23. Accordingly, the average C allele frequency in Chinese population was 0.11. Compared with the wild-type homozygote AA, the variant genotype AC/CC was associated with a statistically increased essential hypertension risk with the pooled OR 1.48 (95% CI: 1.20-1.83, figure 1) in random-effects model. Subsequently, we divided the eligible studies into two subgroups according to their resident geography. The average C allele frequency in Northern Chinese was slightly higher than that among Southern Chinese (0.11 vs. 0.09). Significant association between the risk of hypertension and the AC/CC genotype was observed among both Southern populations (OR=2.24, Table 1 Characteristics of eligible studies included in the meta-analysis.
Study
Year Ethnicity 55, figure 2a ). The strength of the association among Southern Chinese was higher than that among Northern populations. We further performed a meta-analysis for Han Chinese and observed significant association between the risk of essential hypertension and the AC/CC genotype in a total of 17 studies (OR=1.48, 95% CI: 1.10-1.98, figure 2c ).
Cases
In the subgroup analysis by mean age, significant association between hypertension and the AC/CC genotype was observed among older participants (mean age ≥ 60) (OR=1.53, 95% CI: 1.01-2.33, figure 3a) . A similar significant association was also observed for populations whose mean age was 50-60 (OR=1.49, 95% CI: 1.10-2.01, figure 3b) and lower than 40 (OR=1.42, 95% CI: 0.95-2.11, figure 3c ).
Then, we divided these studies into two subgroups according to their sources of controls. For the studies with hospital-based controls, we observed significant association between increased risk of essential hypertension and the AC/CC genotype (OR=1.96, 95% CI: 1.21-3.19, figure 4a ). However, no significant association was found among studies with population-based controls (OR=1.05, 95% CI: 0.92-1.20, figure 4b ).
Sensitivity analyses
We removed two studies by Li et al. 32 and Yuan et al. 45 in the meta-analysis due to the genotype distribution in the control groups of these studies Table 2 The distribution of A1166C genotypes and alleles for cases and controls. Paper SAGE Publications 2010 Los Angeles, London, New Delhi and Singapore slightly deviating from HWE and found the corresponding pooled OR was not substantially altered for the AC/CC genotype (OR=1.55, 95% CI: 1.23-1.94). Similarly, the pooled OR was not qualitatively influenced after exclusion of two heavily weighted studies by Niu et al. 22 and Yuan et al., 45 respectively, suggesting that the results of this meta-analysis were stable.
All studies
Genotypes
Discussion
Since the AT 1 receptor gene A1166C polymorphism was initially reported to be associated with the prevalence of hypertension in the Caucasian population, many researchers have focused their interests on the association between the A1166C polymorphism and hypertension. However, the results of some previous association studies are inconsistent.
Meta-analysis is a powerful tool for summarising results from different studies by producing a single evaluation of the major effect. We collected 30 Chinese case-control studies in this meta-analysis, including 6,045 cases and 5,556 controls in total, with the intention of evaluating the AT 1 receptor A1166C polymorphism and its association with hypertension.
In this meta-analysis, we found a significant association between AC/CC genotype and the increased risk of essential hypertension in Chinese. The average C allele frequency in Chinese population was 0.11, very close to that observed from other Asian populations. 17, 51, 52 However, because data on the function of the AT 1 receptor polymorphism are limited, the mechanism responsible for the association of hypertensive status with the A1166C polymorphism has remained largely unknown. The polymorphism is in a non-coding region of the gene, and therefore the amino acid sequence of the receptor is not altered. It has been hypothesised that it might affect mRNA stability and transcription, or alternatively be in linkage disequilibrium with other polymorphisms. 53, 54 It is well known that China comprises the largest geographical span, the highest number of ethnic groups and the most languages of East Asia. 55 Usually, Chinese living north of the Yangtze River are described as Northern Chinese and ones living south of the Yangtze River are Southern Chinese. Although the association between the AC/CC genotype and hypertension was observed in both Southern populations and Northern Chinese, the strength of the association among Southern populations was slightly higher than that among Northern populations. Moreover, we calculated the AT 1 receptor A/C allele frequencies in the Northern and Southern parts of China and found evidence for lower C allele frequency in Southern Chinese than that in their Northern counterparts. These findings might reflect differences in the genetic backgrounds, in accordance with previous reports in which the genetic differentiation of Southern and Northern populations was considered. 56, 57 It might also be plausible that many other factors influenced the relationship between the AT 1 receptor gene polymorphism and pathological phenotype, such as differences in lifestyle and eating habits between Southern and Northern Chinese. Thus, gene-gene and gene-environment interactions should also be examined in future studies.
There are 56 identified ethnic groups in China, with the Han being the largest group. 55 In this study, the significant association between the A1166C polymorphism and hypertension was found among studies dealing with Han Chinese. There were only two studies dealing with Kazakans (one of the minorities in China), one study respectively dealing with Dongxiang, Tibetans, Yi and Uygur (other minorities). Due to the limited data eligible for meta-analysis, we did not calculate the pooled OR among studies dealing with minorities.
In the stratified analysis, we divided these studies into different subgroups by mean age of the participants. Significant association between hypertension and the AC/CC genotype was observed in the three subgroups. These findings reflect that age might not obviously influence the relationship between the AT 1 receptor A1166C polymorphism and hypertension. However, the results should be confirmed in further studies using large populations.
Source of controls-based stratified analyses demonstrated that the association was significant among studies using hospital-based controls, but not population-based controls. The hospitalbased controls might have selection biases and might not be representative of the general population. As a result, the significance of the genotypes and diseases might be augmented. Carefully conducted studies in well-characterised individuals would be necessary to determine the association of the AT 1 receptor gene polymorphism with hypertension.
There were also some limitations in this metaanalysis. First, because of data limitation, we could not perform additional analyses in other minorities and could not further divide studies into subgroups by gender to investigate any differences in hypertension susceptibility. Second, due to the lack of original data, we did not perform an evaluation of In summary, the present meta-analysis indicates that the AT 1 receptor 1166 AC/CC genotype is associated with susceptibility to hypertension in the Chinese population. Our present results also suggest that further studies using large numbers of participants, well-matched controls and multiethnic groups should be conducted to validate the association.
